Inno, A., G. Bogina, G. Settanni, M. Salgarello, G. Foti, C. Pomari, V. Picece, and S. Gori. “First-Line Tepotinib for a Very Elderly Patient With Metastatic NSCLC Harboring MET Exon 14 Skipping Mutation and High PD-L1 Expression”. Drug Target Insights, vol. 17, no. 1, Oct. 2023, pp. 110-3, doi:10.33393/dti.2023.2626.